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Available online 14 August 2010Carotid endarterectomy is considered the treatment of
choice for patients with focal embolic symptoms and
ipsilateral significant carotid stenosis. In general, these
patients have duplex ultrasound and/or imaging studies
that demonstrate internal carotid stenosis of 70e75% or
greater by ESCT criteria, of 50% or greater by NASCET
criteria or, as in recent years, by duplex scan criteria
scaled to either the ESCT or NASCET criteria. There is little
data and no general guidelines for management of symp-
tomatic patients with marginally significant or lesser
degrees of stenosis. Surgeons frequently performing CEA
over many years only occasionally or infrequently
encounter this small sub-set of symptomatic patients with
hemodynamically insignificant mild or low-moderate
stenosis. Given such a patient, physicians are faced with
a difficult management decision. Few would choose CAS
for symptomatic patients in general and even less likely in
this small group of patients.
The choice of best medical management is difficult given
the recognized incidence of recurrent embolic events and
the current trend for early CEA in patients with an index
TIA, AF or mild stroke and significant stenosis. For the same
reasons it may also be the wrong decision for this small sub-
set of patients. The authors contend that embolic symp-
toms and plaque instability are as important as the degreeDOI of original article: 10.1016/j.ejvs.2010.07.003.
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doi:10.1016/j.ejvs.2010.07.012of stenosis in choosing CEA. The degree of carotid stenosis
does not correlate with the bulk or mass of the plaque, and
certainly not with the luminal surface area available for
endothelial cap rupture and ulceration/embolization
potential. This is obvious when considering the marked
difference between the definition of the degree of stenosis
for the ESCT and NASCET methods. One could argue that
the adverse hemodynamics produced by high grade and
moderate stenosis plays a major role in ulceration and
embolization. While this is probably true, the hemody-
namics of lesser degrees of stenosis as well as that of
normal carotid bulbs is complex with zones of high and low
wall shear stress.
Although the number of patients in this retrospective
study is small, the perioperative stroke rate of 3% (1/31)
and the single late TIA/stroke with a mean follow-up of 4
years are consistent with current standards of excellence.
Of these 31 patients, 25 had less than 70e75% carotid
stenosis by ESCT criteria and less than 50% stenosis by
NASCET criteria. The other six had borderline significant
stenosis. While high grade and clearly moderate carotid
stenosis are usually easily identified, the author’s duplex
and imaging data illustrates the difficulty of obtaining an
accurate and precise estimate of the degree of mild and
low-moderate stenosis. Duplex ultrasound and imaging
results are often at variance in these patients. This is
further complicated by the often confusing issue of the
difference in ESCT and NASCET anatomic criteria as well as
the various duplex scan criteria for the low end of the ofd by Elsevier Ltd. All rights reserved.
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this frustrating problem.
I agree with the author’s conclusion that “plaque
stability (instability) and the number of ischemic events
may be as important as an estimate of the degree of
stenosis” in choosing CEA. While they give soft data on
plaque morphology and some patients had multiple
ischemic events, the value of their paper is support of CEA
for symptomatic patients with mild or low-moderate
stenosis. To go one step further, it may be advisable torecommend CEA for patients with only a clear index
embolic ischemic event and ipsilateral mild or borderline
significant internal carotid stenosis. Because this is a very
small sub-set of symptomatic patients, it is unlikely that
randomized controlled studies can be done with sufficient
power to determine if CEA is the treatment of choice. The
acceptable outcomes of this thoughtful retrospective
experience encourage and support the decision of others
faced with this dilemma to recommend and perform CEA in
otherwise acceptable surgical candidates.
